You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
京新藥業(002020.SZ):擬在巴彥淖爾經濟技術開發區投建中藥生產基地
格隆匯 06-21 19:58

格隆匯6月21日丨京新藥業(002020.SZ)公佈,為有效提升中藥製劑產能,實現公司中藥業務板塊的產業結構升級,公司全資子公司內蒙古京新擬在巴彥淖爾經濟技術開發區投資建設中藥生產基地,項目總用地面積約150畝,總投資約2億元。項目名稱和建設內容最終以相關政府主管機關的批准文件為準。

項目規劃:建設中藥生產基地,包括前處理車間、提取車間、製劑車間、藥材倉庫、綜合倉庫、公用設施等,項目建成投產後預計產能為:年提取中藥材1萬噸、製劑產量6000萬盒。

次投資建設的中藥生產基地擬選址內蒙古京新廠區對面地塊,由內蒙古京新統一規劃建設和管理,新建廠區將建設現代化前處理車間、中藥提取車間及制劑車間,提高中藥材的提取能力,更好的保障成品的質量品質;現有廠區將集中生產康復新液,合理高效佈局產品結構和產能,實現中藥業務板塊的產業結構升級,符合公司的發展戰略和全體股東的利益。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account